SCHEMBL8539708

SCHEMBL8539708

O=C(O)C(CCO)NS(=O)(=O)c1cccc2cccnc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.52
MAPT P10636 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.50
TSHR P16473 1/20 0.50
HTT P42858 1/20 0.50
MMP2 P08253 1/20 0.49
ALDH1A1 P00352 2/20 0.49
PPARG P37231 1/20 0.49
ITGB3 P05106 1/20 0.48
ITGAV P06756 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
POLB P06746 1/20 0.47
FABP1 P07148 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7657489 0.85 GAA (0.52) GAAMAPTNPSR1SMN1; SMN2TSHR
SCHEMBL27995018 0.85 GAA (0.52) GAAMAPTNPSR1SMN1; SMN2TSHR
SCHEMBL5098994 0.84 NTSR1 (0.58) GAAMAPTNPSR1SMN1; SMN2TSHR
SCHEMBL5099014 0.84 NTSR1 (0.58) GAAMAPTNPSR1SMN1; SMN2TSHR
SCHEMBL8385403 0.78 TP53 (0.58) GAAMAPTNPSR1SMN1; SMN2TSHR
SCHEMBL8650770 0.78 TP53 (0.58) GAAMAPTNPSR1SMN1; SMN2TSHR
SCHEMBL7348972 0.78 GAA (0.49) GAAMAPTNPSR1SMN1; SMN2TSHR
SCHEMBL7348982 0.78 GAA (0.49) GAAMAPTNPSR1SMN1; SMN2TSHR
Phenanthroline SCHEMBL27812285 0.77 SLC40A1 (0.53) GAAMAPTNPSR1SMN1; SMN2TSHR
SCHEMBL8954826 0.77 GAA (0.53) GAAMAPTNPSR1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888292-A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY $g(a)v$g(b)3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME HOECHST MARION ROUSSEL (FR) 1999-01-07 EP disclosed
WO-1997034865-A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY αvβ3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME HOECHST MARION ROUSSEL (FR) 1997-09-25 WO disclosed